Fluoroethyl-L-tyrosine (18F)

O-(2-Fluorethyl)-L-thyrosine
Clinical data
Other names	18F-FET; O-(2-(18F)fluoroethyl)-L-tyrosine, O-(2-fluoroethyl)tyrosine, L-(18F)FET
Routes of; administration	intravenous
Identifiers
	IUPAC name (2S)-2-Amino-3-[4-(2-fluoroethoxy)phenyl]propanoic acid;
PubChem CID	54255856;
UNII	3Y68K91A3M;
CompTox Dashboard (EPA)	DTXSID601045942 ;
Chemical and physical data
Formula	C11H14FNO3
Molar mass	227.23 g/mol g·mol−1
3D model (JSmol)	Interactive image;
	SMILES C1=CC(=CC=C1CC(C(=O)O)N)OCCF;
	InChI InChI=1S/C11H14FNO3/c12-5-6-16-9-3-1-8(2-4-9)7-10(13)11(14)15/h1-4,10H,5-7,13H2,(H,14,15)/t10-/m0/s1; Key:QZZYPHBVOQMBAT-JTQLQIEISA-N;

O-(2-Fluorethyl)-L-thyrosine or ¹⁸F-FET is an neuro-oncologic PET tracer.^[2]

References

^ CID 54255856 from PubChem
^ Galldiks, N.; Stoffels, G.; Filss, C.; Rapp, M.; Blau, T.; Tscherpel, C.; Ceccon, G.; Dunkl, V.; Weinzierl, M.; Stoffel, M.; Sabel, M.; Fink, G. R.; Shah, N. J.; Langen, K.-J. (2015). "The use of dynamic O-(2-18F-fluoroethyl)-L-tyrosine PET in the diagnosis of patients with progressive and recurrent glioma". Neuro-Oncology. doi:10.1093/neuonc/nov088.